The following information was provided by the Radiation Health Branch of the
Kentucky Department for Public Health and Safety via email:
On August 26, 2025, the University of Kentucky (UK) Health Center radiation safety officer became aware of a situation that represents what UK believes are a series of possible medical events which occurred from August 22 to August 25, 2025, related to nuclear medicine administrations requiring written directives. Within this date range, a new faculty physician who was in the process of becoming approved as an authorized user (AU) through the UK radiation safety committee (RSC) signed 5 written directives (3 for diagnostic I-131 procedures with a nominal activity of 5 mCi, and 2 for Lu-177 therapy at a 100 mCi activity) despite not having yet received approval under the UK medical broad scope license from the UK RSC. The cases have all been reviewed by a senior AU and no patient harm has been identified. The physician in question has since received approval from the UK RSC. Notifications are in process as required.
This event is under investigation. University of Kentucky will complete an assessment and implement corrective actions.
The written report will follow as required in 15 days.
A Medical Event may indicate potential problems in a medical facility's use of radioactive materials. It does not necessarily result in harm to the patient.